PennyMac Mortgage Investment Trust (PMT) Scheduled to Post Quarterly Earnings on Thursday

PennyMac Mortgage Investment Trust (NYSE:PMT) will issue its quarterly earnings data after the market closes on Thursday, August 1st. Analysts expect the company to announce earnings of $0.48 per share for the quarter.

PennyMac Mortgage Investment Trust (NYSE:PMT) last released its quarterly earnings results on Thursday, May 2nd. The real estate investment trust reported $0.68 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.25. The business had revenue of $106.62 million for the quarter, compared to analysts’ expectations of $89.10 million. PennyMac Mortgage Investment Trust had a net margin of 46.63% and a return on equity of 13.71%. During the same quarter in the previous year, the business posted $0.35 earnings per share. On average, analysts expect PennyMac Mortgage Investment Trust to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

NYSE:PMT traded down $0.03 during trading hours on Wednesday, hitting $22.18. The company had a trading volume of 3,091 shares, compared to its average volume of 623,962. The firm has a market cap of $1.52 billion, a P/E ratio of 11.16, a PEG ratio of 2.15 and a beta of 0.60. The company’s 50-day simple moving average is $21.94. PennyMac Mortgage Investment Trust has a 52 week low of $17.88 and a 52 week high of $22.62. The company has a quick ratio of 0.38, a current ratio of 0.38 and a debt-to-equity ratio of 0.42.

The business also recently declared a quarterly dividend, which was paid on Tuesday, July 30th. Stockholders of record on Monday, July 15th were given a $0.47 dividend. This represents a $1.88 annualized dividend and a dividend yield of 8.48%. The ex-dividend date was Friday, July 12th. PennyMac Mortgage Investment Trust’s dividend payout ratio is presently 94.47%.

Several equities analysts have recently issued reports on PMT shares. Zacks Investment Research raised DLH from a “sell” rating to a “hold” rating in a research report on Tuesday, July 9th. Piper Jaffray Companies set a $75.00 target price on Ionis Pharmaceuticals and gave the stock a “hold” rating in a research report on Friday, May 24th. Finally, Wedbush reissued a “neutral” rating on shares of PennyMac Mortgage Investment Trust in a research report on Friday, July 26th. Five analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $22.25.

In other PennyMac Mortgage Investment Trust news, insider Jeffrey Grogin sold 1,862 shares of the business’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $18.69, for a total value of $34,800.78. Following the completion of the transaction, the insider now owns 36,642 shares of the company’s stock, valued at approximately $684,838.98. The sale was disclosed in a legal filing with the SEC, which is available through this link. 2.45% of the stock is currently owned by insiders.

PennyMac Mortgage Investment Trust Company Profile

PennyMac Mortgage Investment Trust, a specialty finance company, invests primarily in residential mortgage loans and mortgage-related assets in the United States. The company's Correspondent Production segment engages in purchasing, pooling, and reselling newly originated prime credit mortgage loans directly or in the form of mortgage-backed securities (MBS).

Further Reading: What are the most popular ETFs

Earnings History for PennyMac Mortgage Investment Trust (NYSE:PMT)

Receive News & Ratings for PennyMac Mortgage Investment Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PennyMac Mortgage Investment Trust and related companies with's FREE daily email newsletter.